ASX - By Stock
|
AR9 |
Re:
Ann: Quarterly Results Investor Update Webinar
|
|
Bodiezapper
|
198 |
34K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
198
|
34K
|
0
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Trading Halt
|
|
Bodiezapper
|
88 |
40K |
12 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
88
|
40K
|
12
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Quarterly Results Investor Update Webinar
|
|
Bodiezapper
|
198 |
34K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
198
|
34K
|
1
|
|
ASX - By Stock
|
TLG |
Re:
Talga TLG - General Discussion
|
|
Bodiezapper
|
755 |
303K |
10 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
755
|
303K
|
10
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
381
|
75K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
3 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
381
|
75K
|
3
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
381
|
75K
|
2
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
15 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
16K
|
5.7M
|
15
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
0 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
381
|
75K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
2 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
381
|
75K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
5 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
381
|
75K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Bodiezapper
|
391 |
86K |
8 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
86K
|
8
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
0 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
381
|
75K
|
0
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
16 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
16K
|
5.7M
|
16
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Application for quotation of securities - AR9
|
|
Bodiezapper
|
33 |
6.7K |
0 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
33
|
6.7K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Application for quotation of securities - AR9
|
|
Bodiezapper
|
33 |
6.7K |
0 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
33
|
6.7K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
Bodiezapper
|
80 |
26K |
25 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
80
|
26K
|
25
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
2 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
381
|
75K
|
2
|
|
ASX - By Stock
|
HCH |
Re:
HCH potential Water business
|
|
Bodiezapper
|
85 |
28K |
1 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
85
|
28K
|
1
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Talga and SQM enter lithium partnership agreement in Sweden
|
|
Bodiezapper
|
73 |
37K |
23 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
73
|
37K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Bodiezapper
|
80 |
26K |
35 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
26K
|
35
|
|
ASX - By Stock
|
TLG |
Re:
TLG Chart
|
|
Bodiezapper
|
4.2K |
1.5M |
16 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
4.2K
|
1.5M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
Bodiezapper
|
82 |
27K |
24 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
82
|
27K
|
24
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
381
|
75K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
Bodiezapper
|
82 |
27K |
36 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
27K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
Bodiezapper
|
82 |
27K |
62 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
27K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
Bodiezapper
|
110 |
39K |
20 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
39K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
Bodiezapper
|
110 |
39K |
23 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
39K
|
23
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
4 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
381
|
75K
|
4
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Copper River Technologies Joins AR9 Channel Partner Program
|
|
Bodiezapper
|
13 |
3.5K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 to Present at Henslow Defence and Security Conference
|
|
Bodiezapper
|
381 |
75K |
0 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
381
|
75K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Investor Presentation - Quarterly Results
|
|
Bodiezapper
|
211 |
43K |
1 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
211
|
43K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Investor Presentation - Quarterly Results
|
|
Bodiezapper
|
211 |
43K |
2 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
211
|
43K
|
2
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
16K
|
5.7M
|
3
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
16K
|
5.7M
|
5
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Investor Presentation - Quarterly Results
|
|
Bodiezapper
|
211 |
43K |
10 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
211
|
43K
|
10
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Talga defines larger graphite target in Sweden
|
|
Bodiezapper
|
27 |
13K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
27
|
13K
|
12
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
13 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
16K
|
5.7M
|
13
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
13 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
16K
|
5.7M
|
13
|
|
ASX - By Stock
|
HCH |
Re:
Ann: Trading Halt
|
|
Bodiezapper
|
394 |
77K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
394
|
77K
|
5
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
16K
|
5.7M
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Awarded $466,840 Contract from Penten
|
|
Bodiezapper
|
9 |
3.1K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
9
|
3.1K
|
0
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Awarded $466,840 Contract from Penten
|
|
Bodiezapper
|
9 |
3.1K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
9
|
3.1K
|
7
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Bodiezapper
|
16K |
5.7M |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
16K
|
5.7M
|
6
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
Bodiezapper
|
112 |
27K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
112
|
27K
|
2
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
Bodiezapper
|
112 |
27K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
112
|
27K
|
1
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: archTIS Appoints Andrew Burns as Chief Financial Officer
|
|
Bodiezapper
|
10 |
3.8K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
10
|
3.8K
|
3
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
Bodiezapper
|
112 |
27K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
112
|
27K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Bodiezapper
|
10 |
3.4K |
9 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
10
|
3.4K
|
9
|
|
ASX - By Stock
|
AR9 |
Re:
Media
|
|
Bodiezapper
|
112 |
27K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
112
|
27K
|
1
|
|